This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Heidelberg Pharma Ag. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Brigitte Heckl-Oestreicher: Innovator in Anti-Cancer Research
Introduction
Brigitte Heckl-Oestreicher is a prominent inventor based in Heidelberg, Germany. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds with anti-cancer properties. Her innovative work has the potential to impact cancer treatment significantly.
Latest Patents
Heckl-Oestreicher holds a patent for nucleotide lipid ester derivatives. This invention involves specific lipid esters of halogenated nucleotides, which have been shown to possess anti-cancer properties. The patent outlines the compounds' formula, their pharmaceutical compositions, methods of synthesis, and their application in treating malignant tumors. She has 1 patent to her name.
Career Highlights
Brigitte is associated with Heidelberg Pharma AG, where she continues her research and development efforts. Her work focuses on creating innovative solutions for cancer treatment, showcasing her dedication to advancing medical science.
Collaborations
Throughout her career, she has collaborated with notable colleagues, including Dieter Herrmann and Christoph Mueller. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Brigitte Heckl-Oestreicher's contributions to anti-cancer research through her innovative patents and collaborations highlight her role as a leading inventor in the pharmaceutical field. Her work continues to inspire advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile